Sugi Predict

Sugi Predict / Compounds / SCHEMBL3082156

SCHEMBL3082156

SCHEMBL3082156

[Li]c1cccc2cc3ccccc3cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 11/20 0.45
▸ KDM4E B2RXH2 3/20 0.45
▸ GAA P10253 2/20 0.45
▸ HSD17B10 Q99714 7/20 0.44
▸ HIF1A Q16665 4/20 0.44
▸ CYP1B1 Q16678 1/20 0.44
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ CYP1A2 P05177 4/20 0.40
▸ ACHE P22303 2/20 0.40
▸ ERBB2 P04626 1/20 0.40
▸ FYN P06241 1/20 0.40
▸ MAOA P21397 1/20 0.40
▸ AHR P35869 1/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ NQO1 P15559 1/20 0.38
▸ HPGD P15428 5/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31318311 1.00 ALDH1A1 (0.45) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL11081181 0.92 ALDH1A1 (0.43) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL1235563 0.82 CYP1A2 (0.48) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL3891801 0.81 CYP1A2 (0.47) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL29658168 0.79 ALDH1A1 (0.44) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL139837 0.79 ALDH1A1 (0.44) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL9017260 0.79 ALDH1A1 (0.34) ALDH1A1HSD17B10HIF1ACYP1B1CYP1A2
SCHEMBL8664444 0.76 ALDH1A1 (0.52) ALDH1A1KDM4EGAAHSD17B10HIF1A
Boric Acid SCHEMBL1517533 0.76 CYP1A2 (0.43) ALDH1A1KDM4EGAAHSD17B10HIF1A
SCHEMBL238050 0.76 ALDH1A1 (0.53) ALDH1A1HSD17B10HIF1ACYP1B1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115884812-A Cleaning composition 株式会社资生堂 2023-03-31 — — CN disclosed
CN-114369101-B Preparation method of chalcogen organic semiconductor 西北大学 2023-03-28 — — CN disclosed
CN-115702869-A Cleaning agent composition and cleaning agent product 株式会社资生堂 2023-02-17 — — CN disclosed
CN-115531248-A Oil-in-water type emulsified solid cosmetic 株式会社资生堂 2022-12-30 — — CN disclosed
CN-110770173-B Titanium dioxide powder and powdery cosmetic containing the same 株式会社资生堂 2022-11-29 — — CN disclosed
CN-115209870-A Cosmetic composition 信越化学工业株式会社 2022-10-18 — — CN disclosed
CN-115209878-A Soft chewable shaped bodies for administration to animals 拜耳动物保健有限责任公司 2022-10-18 — — CN disclosed
CN-111032796-B Ink composition for ink jet, ink jet cartridge, and cosmetic device 株式会社资生堂 2022-07-08 — — CN disclosed
CN-114522115-A Wrinkle-improving agent 宝丽化成工业有限公司 2022-05-24 — — CN disclosed
CN-109715133-B Cosmetic raw material and oil-in-water emulsion cosmetic using core-shell fine particles 株式会社资生堂 2022-05-17 — — CN disclosed
US-7794632-B2 Process for the preparation of pure aryllithium compounds and their use CHEMETALL GMBH (DE) 2010-09-14 — — US disclosed
CN-101142279-A Silicone emulsion, method of preparing same, and cosmetic ingredient DOW CORNING (US) 2008-03-12 — — CN disclosed
US-20070187847-A1 Process for the preparation of pure aryllithium compounds and their use EMMEL UTE 2007-08-16 — — US disclosed
EP-1295887-B1 Preparation of pure aryl lithium compounds CHEMETALL GMBH (DE) 2006-08-02 — — EP disclosed
US-20060091569-A1 Process for the preparation of pure aryllithium compounds and their use EMMEL UTE 2006-05-04 — — US disclosed
US-20030155665-A1 Process for the preparation of pure aryllithium compounds and their use CHEMETALL GMBH (DE) 2003-08-21 — — US disclosed
EP-1295887-A1 Preparation of pure aryl lithium compounds and their use Chemetall GmbH (DE) 2003-03-26 — — EP disclosed
EP-0856522-B1 A MULTIFUNCTIONAL ORGANIC ALKALI METAL INITIATOR AND ITS SYNTHESIS, ANONIC POLYMERISED STAR POLYMERS AND THEIR PREPARATION CHINA PETROCHEMICAL CORP (CN) 2003-01-02 — — EP disclosed
US-6150487-A POLYMERIZATION CATALYSTS FOR FORMING STAR POLYMERS CHINA PETROCHEMICAL CORPORATION (CN) 2000-11-21 — — US disclosed
EP-0856522-A1 A MULTIFUNCTIONAL ORGANIC ALKALI METAL INITIATOR AND ITS SYNTHESIS, ANONIC POLYMERISED STAR POLYMERS AND THEIR PREPARATION CHINA PETROCHEMICAL CORPORATION (CN) 1998-08-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060091569-A1 Process for the preparation of pure aryllithium compounds and their use TYR, MLLT3, MLLT1 ALDH1A1 3105/4885KDM4E 362/4885GAA 1209/4885
US-20070187847-A1 Process for the preparation of pure aryllithium compounds and their use TYR, MLLT3, MLLT1 ALDH1A1 3105/4885KDM4E 362/4885GAA 1209/4885
US-20030155665-A1 Process for the preparation of pure aryllithium compounds and their use TYR, MLLT3, MLLT1 ALDH1A1 3105/4885KDM4E 362/4885GAA 1209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.